Skip to main content
Clinical Trials/IRCT2015060622562N1
IRCT2015060622562N1
Completed
Phase 2

The effects of selenium supplementation on advanced glycation end products, biomarkers of inflammatory and oxidative stress in diabetic nephropathy patients in comparison with placebo: a randomized double-blinded controlled clinical trial

Vice chancellor for research, Kashan University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
non-insulin-dependent diabetes mellitus with renal complications
Sponsor
Vice chancellor for research, Kashan University of Medical Sciences
Enrollment
60
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice chancellor for research, Kashan University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Diabetic nephropathy with a proteinuria level of \>0\.3 g/24 hours
  • With or without circulating levels of serum creatinine

Exclusion Criteria

  • The consumption of selenium supplements within 3 months before beginning of the study
  • Patients with uncontrolled diabetes
  • Pregnant women
  • Liver diseases
  • Inflammatory diseases
  • Bacteriuria
  • Urinary tract infection
  • History of hospital admission within 3 months

Outcomes

Primary Outcomes

Not specified

Similar Trials